Literature DB >> 17979625

The PI3K/Akt pathway and its downstream transcriptional factors as targets for chemoprevention.

Xinhai Zhang1, Boquan Jin, Chuanshu Huang.   

Abstract

The PI3K/Akt signalling pathway and its downstream transcription factors have been intensively studied for their role in cell proliferation, survival, cycle control, as well as other cellular functions. There is growing evidence showing that dysregulation of this pathway also plays an essential role in cancer development. The overexpression or permanent activation of RTKs and GPCRs, as well as the exposure to environmental carcinogens cause constant activation of PI3K/Akt. On the other hand, PI3K/Akt themselves can also become hyperactivated due to gene amplification or PTEN inactivation. Consequently, the targets downstream of PI3K/Akt can be abnormally activated, which promote proliferation and survival of cancer cells in carcinogenesis. Among these targets we find that the NFkappaB and AP-1 are the most interesting. Therefore, methods and compounds aiming to inhibit the altered components of this pathway can simultaneously prevent the proliferation of tumor cells and sensitize them toward apoptosis. To this regard, the natural compounds from vegetables and fruits with high affinity and non toxicity to target the PI3K/Akt pathway and prevent cancer are attractive.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979625     DOI: 10.2174/156800907780809741

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  27 in total

1.  Mutated KRAS results in overexpression of DUSP4, a MAP-kinase phosphatase, and SMYD3, a histone methyltransferase, in rectal carcinomas.

Authors:  Jochen Gaedcke; Marian Grade; Klaus Jung; Jordi Camps; Peter Jo; Georg Emons; Anastasia Gehoff; Ulrich Sax; Markus Schirmer; Heinz Becker; Tim Beissbarth; Thomas Ried; B Michael Ghadimi
Journal:  Genes Chromosomes Cancer       Date:  2010-11       Impact factor: 5.006

2.  Inhibition of the PI3K pathway suppresses hormonal secretion and limits growth in pheochromocytoma cells.

Authors:  Joel T Adler; Daniel G Hottinger; Muthusamy Kunnimalaiyaan; Herbert Chen
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

3.  Verrucarin A alters cell-cycle regulatory proteins and induces apoptosis through reactive oxygen species-dependent p38MAPK activation in the human breast cancer cell line MCF-7.

Authors:  Kandasamy Palanivel; Veerasamy Kanimozhi; Balamuthu Kadalmani
Journal:  Tumour Biol       Date:  2014-07-16

4.  Caffeic acid phenethyl ester (CAPE), derived from a honeybee product propolis, exhibits a diversity of anti-tumor effects in pre-clinical models of human breast cancer.

Authors:  Jing Wu; Coral Omene; Jerzy Karkoszka; Maarten Bosland; Jonathan Eckard; Catherine B Klein; Krystyna Frenkel
Journal:  Cancer Lett       Date:  2011-05-13       Impact factor: 8.679

5.  Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.

Authors:  Jin Chen; Feng-Ling Wang; Wei-Dong Chen
Journal:  Mol Biol Rep       Date:  2014-03-07       Impact factor: 2.316

6.  Urinary bladder organ hypertrophy is partially regulated by Akt1-mediated protein synthesis pathway.

Authors:  Li-Ya Qiao; Chunmei Xia; Shanwei Shen; Seong Ho Lee; Paul H Ratz; Matthew O Fraser; Amy Miner; John E Speich; Jeffrey J Lysiak; William D Steers
Journal:  Life Sci       Date:  2018-03-21       Impact factor: 5.037

7.  The Akt inhibitor ISC-4 activates prostate apoptosis response protein-4 and reduces colon tumor growth in a nude mouse model.

Authors:  Arun K Sharma; Christina L Kline; Arthur Berg; Shantu Amin; Rosalyn B Irby
Journal:  Clin Cancer Res       Date:  2011-05-09       Impact factor: 12.531

8.  PI3K/Akt/JNK/c-Jun signaling pathway is a mediator for arsenite-induced cyclin D1 expression and cell growth in human bronchial epithelial cells.

Authors:  Jin Ding; Beifang Ning; Yi Huang; Dongyun Zhang; Jingxia Li; Chang-Yan Chen; Chuanshu Huang
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

9.  Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.

Authors:  Paolo Onori; Sharon DeMorrow; Eugenio Gaudio; Antonio Franchitto; Romina Mancinelli; Julie Venter; Shelley Kopriva; Yoshiyuki Ueno; Domenico Alvaro; Jennifer Savage; Gianfranco Alpini; Heather Francis
Journal:  Int J Cancer       Date:  2009-08-01       Impact factor: 7.396

10.  Thioredoxin-like protein 2 is overexpressed in colon cancer and promotes cancer cell metastasis by interaction with ran.

Authors:  Yuanyuan Lu; Xiaodi Zhao; Kai Li; Guanhong Luo; Yongzhan Nie; Yongquan Shi; Yi Zhou; Gui Ren; Bin Feng; Zhenxiong Liu; Yan Pan; Ting Li; Xuegang Guo; Kaichun Wu; Antonio Miranda-Vizuete; Xin Wang; Daiming Fan
Journal:  Antioxid Redox Signal       Date:  2013-03-04       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.